Healthcare - Biotechnology - NASDAQ - US
$ 2.61
-6.79 %
$ 43.9 M
Market Cap
-0.61
P/E
Price Target
Average
--10.60%
Revenue Forecast
Estimate
103.10%
EBIT
Estimate
61.53%
Net Income
Estimate
37.13%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
OncoCyte Corporation
Wall Street analysts predict an average 1-year price target for OCX of $2.33 , with forecasts ranging from a low of $0.5 to a high of $4.25 .
OCX Lowest Price Target
Wall Street Target
0.5 USD
-80.84%
OCX Average Price Target
Wall Street Target
2.33 USD
-10.60%
OCX Highest Price Target
Wall Street Target
4.25 USD
62.84%
REVENUE FORECAST
Revenue Forecast Chart OCX
EBIT FORECAST
EBIT Forecast Chart OCX
NET INCOME FORECAST
Net Income Chart OCX